glp-1 colorectal cancer risk study november 2025 drugs and cancer: the headline is exciting. The full picture is more nuanced. New research from @ascocancer 2026 shows patients on GLP-1 medications like semaglutide were up to 50% less likely GLP-1 Associated With Colorectal Cancer

Available Wegovy doses There are 6 Wegovy dosages for weight loss: Wegovy 0.25mg Wegovy 0.5mg Wegovy 1mg Wegovy 1.7mg Wegovy 2.4mg Wegovy 7.2mg The active ingredient in Wegovy is semaglutide, so this means Wegovy 0.25mg will contain 0.25mg of semaglutide per dose, and so on for each Wegovy dose

The review is the first to compare efficacy of the three FDA-approved GLP-1 medications in non-diabetic patients using the drugs for weight loss

I love an iced coffee nothings better than an iced coffee

By modulating the inflammatory response, TB-500 may contribute to a more favorable healing environment

Tesamorelin/Ipamorelin Blend typically comes in a 10 mg vial